Search results for "phases"

showing 10 items of 282 documents

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

2010

Abstract Abstract 4827 Background: The introduction of HAART has significantly improved the outcome of pts with HD-HIV. However there are no data on the long term follow-up of HD-HIV pts treated with conventional chemotherapy (CT) regimens. In 2002, we reported the results of a prospective phase II study with the intensive 12-week CT with adjuvant radiotherapy (Stanford V) and concomitant HAART in 59 pts (Spina et al. Blood 2002;100:1984-1988). Methods: To analyze the long term outcome of patients included in the Stanford V and HAART protocol. Results: The median follow-up is 67months (range 3–156 months The 5-yr overall survival (OS), freedom from progression (FFP), disease free survival a…

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologyHuman immunodeficiency virus (HIV)Phases of clinical researchCell BiologyHematologyStanford V regimenLong term resultschemotherapymedicine.disease_causemedicine.diseaseBiochemistrySettore MED/15 - Malattie Del SangueSurgeryStanford VIdiopathic pneumonia syndromeInternal medicineConcomitantmedicineHodgkin's diseaseFresh frozen plasmabusinessBlood
researchProduct

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthr…

2012

Abstract Abstract 46 Background Elacytarabine, a fatty acid derivative (elaidic acid ester) of cytarabine, has pharmacokinetic and pharmacodynamic properties that may lead to improved clinical outcomes (Adema et al., 2011) compared to cytarabine. A phase I study had established 1000 mg/m2/d continuous infusion on d 1 – 5 as a safe and effective dose of elacytarabine given in combination with idarubicin at 12 mg/m2/d IV d 1 – 3 (Giles et al., 2012). Mechanism of Action The mechanism of action is similar to cytarabine, but unlike cytarabine, plasma elimination half-life is long, intracellular distribution is prolonged and activity is independent of membrane nucleoside transporters. Resistance…

Oncologymedicine.medical_specialtyeducation.field_of_studyCombination therapyAnthracyclineElacytarabinebusiness.industryImmunologyPopulationPhases of clinical researchCell BiologyHematologyPharmacologyBiochemistryRegimenInternal medicineCytarabineMedicineIdarubicinbusinesseducationmedicine.drugBlood
researchProduct

Supportive Efficacy Analyses for the Phase 3 Study of Temsirolimus Versus Investigator’s Choice Therapy for the Treatment of Patients with Relapsed o…

2008

Abstract Temsirolimus (Torisel®) is a specific inhibitor of the mTOR kinase with antitumor activity in patients with relapsed or refractory mantle cell lymphoma. In a phase 3, randomized, open-label study, patients treated with temsirolimus 175 mg weekly 3 times followed by 75 mg weekly (175/75-mg) had significantly longer progression-free survival (PFS) than those treated with investigator’s choice therapy (p-value temsirolimus: investigator’s choice = 0.0009; hazard ratio = 0.44; 97.5% CI = 0.25, 0.78; Hess et al. J Clin Oncol.2008, 28:abs 8513). Patients treated with temsirolimus 175 mg weekly 3 times followed by 25 mg weekly (175/25-mg) showed a trend towards longer PFS than those treat…

Oncologymedicine.medical_specialtyeducation.field_of_studyRandomizationbusiness.industryProportional hazards modelImmunologyPopulationHazard ratioPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryTemsirolimusSurgeryInternal medicineClinical endpointmedicinebusinesseducationProgressive diseasemedicine.drugBlood
researchProduct

Randomized, Double-Blind Study of Sonidegib (Lde225) in Patients (Pts) with Advanced Basal Cell Carcinoma (Bcc)

2014

ABSTRACT Aim: The BOLT phase 2 study, comparing 2 doses of sonidegib, a hedgehog pathway inhibitor (HhPI), in pts with advanced BCC (aBCC; NCT01327053), met its primary endpoint of objective response rate ≥30% in both arms in analyses of data collected up to 6 mo after randomization of the last pt (June 28, 2013, cutoff; median follow-up [f/u], 13.9 mo; Migden, ASCO 2014). Associations of GLI1 (marker of Hh pathway activation) with clinical outcome (as of June 28, 2013) and updated 12-mo efficacy and safety data (Dec 31, 2013, cutoff; median f/u, 20.0 mo) are presented. Methods: Pts with locally advanced BCC (LaBCC; n = 194) not amenable to curative surgery or radiation or metastatic BCC (m…

Oncologymedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationPhases of clinical researchHematologymedicine.diseaseSonidegibDouble blind studychemistry.chemical_compoundOncologychemistryInternal medicineClinical endpointMedicineIn patientBasal cell carcinomabusinesseducationProgressive diseaseAnnals of Oncology
researchProduct

Purification of Lindblad dynamics, geometry of mixed states and geometric phases

2015

We propose a nonlinear Schr\"odinger equation in a Hilbert space enlarged with an ancilla such that the partial trace of its solution obeys to the Lindblad equation of an open quantum system. The dynamics involved by this nonlinear Schr\"odinger equation constitutes then a purification of the Lindbladian dynamics. This nonlinear equation is compared with other Schr\"odinger like equations appearing in the theory of open systems. We study the (non adiabatic) geometric phases involved by this purification and show that our theory unifies several definitions of geometric phases for open systems which have been previously proposed. We study the geometry involved by this purification and show th…

Partial traceQuantum information[PHYS.MPHY]Physics [physics]/Mathematical Physics [math-ph]FOS: Physical sciencesGeneral Physics and AstronomyGeometry01 natural sciencessymbols.namesakeOpen quantum system0103 physical sciencesGauge theory0101 mathematicsQuantum information010306 general physicsAdiabatic processNonlinear Schrödinger equationMathematical PhysicsMathematicsQuantum PhysicsLindblad equation010102 general mathematicsFibre bundlesHilbert spaceCategoryMathematical Physics (math-ph)Quantum PhysicsMathematics::Spectral TheoryGeometric phasesDynamics of open quantum systemsMixed statessymbolsGeometry and TopologyQuantum Physics (quant-ph)
researchProduct

Half-width plots, a simple tool to predict peak shape, reveal column kinetics and characterise chromatographic columns in liquid chromatography: Stat…

2013

Peak profiles in chromatography are characterised by their height, position, width and asymmetry; the two latter depend on the values of the left and right peak half-widths. Simple correlations have been found between the peak half-widths and the retention times. The representation of such correlations has been called half-width plots. For isocratic elution, the plots are parabolic, although often, the parabolas can be approximated to straight-lines. The plots can be obtained with the half-widths/retention time data for a set of solutes experiencing the same kinetics, eluted with a mobile phase at fixed or varying composition. When the analysed solutes experience different resistance to mas…

Peak profiles in chromatography are characterised by their height position width and asymmetry; the two latter depend on the values of the left and right peak half-widths. Simple correlations have been found between the peak half-widths and the retention times. The representation of such correlations has been called half-width plots. For isocratic elution the plots are parabolic although often the parabolas can be approximated to straight-lines. The plots can be obtained with the half-widths/retention time data for a set of solutes experiencing the same kinetics eluted with a mobile phase at fixed or varying composition. When the analysed solutes experience different resistance to mass transfer the plots will be solute dependent and should be obtained with the data for each solute eluted with mobile phases at varying composition. The half-width plots approach is a simple tool that facilitates the prediction of peak shape (width and asymmetry) with optimisation purposes reveal the interaction kinetics of solutes in different columns and characterise chromatographic columns. This work shows half-width plots for different situations in isocratic elution including the use of different flows the effect of temperature the modification of the stationary phase surface by an additive the existence of specific interactions within the column and the comparison of columns. The adaptation to gradient elution is also described. Previous knowledge on half-width plots is structured and analysed to which new results are added.Work (thermodynamics)Column characterisationmedia_common.quotation_subjectKineticsLiquid chromatographyAnalytical chemistryHalf-widthsInteraction kineticsBiochemistryAsymmetryAnalytical ChemistryPeak shapeColumn (typography)Position (vector)Mass transferPhase (matter)media_commonChromatographyElutionChemistryOrganic ChemistryGeneral MedicineModels TheoreticalKineticsPredictionChromatography LiquidJournal of Chromatography A
researchProduct

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

2021

AbstractAim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortalit…

Pediatricsmedicine.medical_specialty2019-20 coronavirus outbreakAspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki diseaseReview030204 cardiovascular system & hematologyMucocutaneous Lymph Node SyndromeDiagnosis Differential03 medical and health sciences0302 clinical medicine030225 pediatricshemic and lymphatic diseasesmedicineHumansChildCoronary artery abnormalitieChildrenIntravenous immunoglobulinAspirinAspirinKawasaki diseasebusiness.industryClinical courselcsh:RJ1-570Immunoglobulins Intravenouslcsh:PediatricsGeneral MedicineDelayed treatmentmedicine.diseasePrognosisSettore MED/38Disease phasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAEl NiñoItalyTreatment modalityDisease ProgressionAspirin Children Coronary artery abnormalities Intravenous immunoglobulin Kawasaki diseaseKawasaki diseasebusinessCoronary artery abnormalitiesmedicine.drug
researchProduct

Comparative enantioseparation of planar chiral ferrocenes on polysaccharide‐based chiral stationary phases

2022

Planar chiral ferrocenes are well-known compounds that have attracted interest for application in synthesis, catalysis, material science, and medicinal chemistry for several decades. In spite of the fact that asymmetric synthesis procedures for obtaining enantiomerically enriched ferrocenes are available, sometimes, the accessible enantiomeric excess of the chiral products is unsatisfactory. In such cases and for resolution of racemic planar chiral ferrocenes, enantioselective high-performance liquid chromatography (HPLC) on polysaccharide-based chiral stationary phases (CSPs) has been used in quite a few literature articles. However, although moderate/high enantioselectivities have been ob…

PharmacologyPlanar chiralityMetallocenesElectrostatic potentialelectrostatic potential; enantioseparation; ferrocenes; planar chirality; polysaccharide-based chiral stationary phasesOrganic ChemistryStereoisomerismQuímica analíticaSettore CHIM/06 - Chimica OrganicaPolysaccharide-based chiral stationary phasesCatalysisEnantioseparationAnalytical ChemistryPolysaccharidesDrug DiscoverySettore CHIM/01 - Chimica AnaliticaAmyloseFerrocenesChromatography High Pressure LiquidSpectroscopyChirality
researchProduct

Mass spectrometry of surfactant aggregates.

2012

In contrast with the enormous amount of literature produced during many decades in the field of surfactant aggregation in liquid, liquid crystalline and solid phases, only a few investigations concerning surfactant self-assembling in the gas phase as charged aggregates have been carried out until now. This lack of interest is disappointing in view of the remarkable theoretical and practical importance of the inherent knowledge. The absence of surfactant–solvent interactions makes it easier to study the role of surfactant–surfactant forces in determining their peculiar self-assembling features as well as the ability of these assemblies to incorporate selected solubilizate molecules. Thus, t…

Phase transitionLiquid crystallineChemistryAnalytical chemistrySupramolecular chemistryGeneral MedicineMass spectrometryAtomic and Molecular Physics and OpticsMass SpectrometryPhase TransitionGas phaseSurface-Active AgentsPulmonary surfactantChemical physicsSolid phasesMoleculeGasesSpectroscopyEuropean journal of mass spectrometry (Chichester, England)
researchProduct

Orientation and Dynamics of ZnO Nanorod Liquid Crystals in Electric Fields.

2010

ZnO nanorod polymer hybrids (i.e., ZnO nanorods coated with a block copolymer with a short anchor block (dopamine) and a longer solubilizing block of polystyrene (PS)) form liquid crystalline (LC) phases if they are dispersed at high concentration e.g., in a PS oligomer matrix. Due to the high mobility of the low T(g)-matrix the nanorod polymer hybrids show a switching behavior under an applied AC electric field. Hence, the orientation of the nanorod mesogens can be changed from planar (parallel to the substrate) to homeotropic (perpendicular) in full analogy to the switching of low molecular liquid crystals in an electric field. Dielectric measurements show that such a switching is mainly …

Phase transitionMaterials sciencePolymers and PlasticsHomeotropic alignmentDielectricpolystyrenesemiconducting nanorodspressureliquid crystalsLiquid crystalElectric fieldnanostructuresPolymer chemistryMaterials Chemistryarraysnanoparticle polymer compositespolymerschemistry.chemical_classificationbehaviorbusiness.industryOrganic ChemistryPolymermatrixelectric fieldblock copolymersDipolechemistryOptoelectronicsNanorodphasesbusinesscharge-transportMacromolecular rapid communications
researchProduct